FindTrial
Sign In

Validation of combination of PHES and Stroop test in the diagnosis of covert hepatic encephalopathy

Validation of combination of PHES and Stroop test in the diagnosis of covert hepatic encephalopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019954
Enrollment
Unknown
Registered
2018-12-09
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic encephalopathy

Interventions

Gold Standard:Psychometric hepatic encephalopathy score
Index test:Stroop&#32
test&#32
(Encephalopathy)

Sponsors

Changzheng Hospital, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Willing to sign informed consent; (2) Age>18 year; (3) Both inpatients and outpatients with cirrhosis.

Exclusion criteria

Exclusion criteria: (1) a history of mental disease, such as Parkinsons disease, dementia, depression, bipolar disease (BD), Alzheimer disease (AZD), schizophrenia, epilepsy, cerebrovascular disease; (2) psychoactive medications within 4 weeks; (3) alcohol intake more than 50g per day; (4) red-green color blindness, dyslexia or impaired comprehension; (5) without previous and current OHE.

Design outcomes

Primary

MeasureTime frame
Cognitive function;—

Countries

China

Contacts

Public ContactZeng Xin

Department of Gastroenterology, Changzheng Hospital, Shanghai

zengxinmd1978@163.com+86 021 81885346

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026